Rajderkar Sudha Sunil, Paraiso Kitt, Amaral Maria Luisa, Kosicki Michael, Cook Laura E, Darbellay Fabrice, Spurrell Cailyn H, Osterwalder Marco, Zhu Yiwen, Wu Han, Afzal Sarah Yasmeen, Blow Matthew J, Kelman Guy, Barozzi Iros, Fukuda-Yuzawa Yoko, Akiyama Jennifer A, Afzal Veena, Tran Stella, Plajzer-Frick Ingrid, Novak Catherine S, Kato Momoe, Hunter Riana D, von Maydell Kianna, Wang Allen, Lin Lin, Preissl Sebastian, Lisgo Steven, Ren Bing, Dickel Diane E, Pennacchio Len A, Visel Axel
Environmental Genomics & System Biology Division, Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, CA 94720, USA.
Bioinformatics and Systems Biology Graduate Program, University of California San Diego, La Jolla, CA, USA.
bioRxiv. 2023 Jun 26:2023.06.26.546603. doi: 10.1101/2023.06.26.546603.
The genetic basis of craniofacial birth defects and general variation in human facial shape remains poorly understood. Distant-acting transcriptional enhancers are a major category of non-coding genome function and have been shown to control the fine-tuned spatiotemporal expression of genes during critical stages of craniofacial development. However, a lack of accurate maps of the genomic location and cell type-specific activities of all craniofacial enhancers prevents their systematic exploration in human genetics studies. Here, we combined histone modification and chromatin accessibility profiling from different stages of human craniofacial development with single-cell analyses of the developing mouse face to create a comprehensive catalogue of the regulatory landscape of facial development at tissue- and single cell-resolution. In total, we identified approximately 14,000 enhancers across seven developmental stages from weeks 4 through 8 of human embryonic face development. We used transgenic mouse reporter assays to determine the activity patterns of human face enhancers predicted from these data. Across 16 validated human enhancers, we observed a rich diversity of craniofacial subregions in which these enhancers are active . To annotate the cell type specificities of human-mouse conserved enhancers, we performed single-cell RNA-seq and single-nucleus ATAC-seq of mouse craniofacial tissues from embryonic days e11.5 to e15.5. By integrating these data across species, we find that the majority (56%) of human craniofacial enhancers are functionally conserved in mice, providing cell type- and embryonic stage-resolved predictions of their activity profiles. Using retrospective analysis of known craniofacial enhancers in combination with single cell-resolved transgenic reporter assays, we demonstrate the utility of these data for predicting the cell type specificity of enhancers. Taken together, our data provide an expansive resource for genetic and developmental studies of human craniofacial development.
颅面出生缺陷的遗传基础以及人类面部形状的一般变异仍未得到充分了解。远距离作用的转录增强子是一类主要的非编码基因组功能,已被证明在颅面发育的关键阶段控制基因的精细时空表达。然而,缺乏所有颅面增强子的基因组位置和细胞类型特异性活性的精确图谱,阻碍了它们在人类遗传学研究中的系统探索。在这里,我们将人类颅面发育不同阶段的组蛋白修饰和染色质可及性分析与发育中小鼠面部的单细胞分析相结合,以创建一个在组织和单细胞分辨率下的面部发育调控景观的综合目录。我们总共在人类胚胎面部发育第4周 到第8周的七个发育阶段中鉴定出约14,000个增强子。我们使用转基因小鼠报告基因检测来确定从这些数据预测的人类面部增强子的活性模式。在16个经过验证的人类增强子中,我们观察到这些增强子活跃的颅面亚区域具有丰富的多样性。为了注释人类-小鼠保守增强子的细胞类型特异性,我们对胚胎期e11.5至e15.5的小鼠颅面组织进行了单细胞RNA测序和单核ATAC测序。通过整合跨物种的这些数据,我们发现大多数(56%)人类颅面增强子在小鼠中功能保守,提供了它们活性谱的细胞类型和胚胎阶段解析预测。通过对已知颅面增强子的回顾性分析与单细胞解析的转基因报告基因检测相结合,我们证明了这些数据在预测增强子细胞类型特异性方面的实用性。总之,我们的数据为人类颅面发育的遗传和发育研究提供了丰富的资源。